Lawsuit: Birth control mix-up results in 113

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
Lawsuit: Birth control mix-up results in 113 pregnancies

By MARYCLAIRE DALE
Associated Press


The lawsuit, filed in Philadelphia, is brought against Qualitest Inc., a subsidiary of the Irish drug-maker Endo Pharmaceuticals Inc., but names Patheon as well as Vintage Pharmaceuticals as defendants



PHILADELPHIA (AP) - More than 100 women who blame their pregnancies on errant birth control packaging have joined a negligence lawsuit filed in Philadelphia against several drug companies.

The lawsuit follows a 2011 recall of more than 500,000 blister packs after an Iowa customer found the pills packaged out of order, potentially increasing the chance of getting pregnant.

All but four of the 117 women involved in the lawsuit became pregnant and 94 went on to give birth.

They are now suing Endo Pharmaceuticals Inc. and other companies that made or distributed the pills under various brand names. The women are seeking damages for lost income, medical costs and, in some cases, the cost of raising their children.

A spokeswoman at Endo's U.S. headquarters in Malvern did not immediately return a message Thursday seeking comment.

The lawsuit filed last week in Philadelphia came days after a federal judge in Georgia refused to grant class-action certification to a similar suit filed there.

U.S. District Judge Steve C. Jones noted in his ruling that only 53 of the half-million recalled blister packs had the pills arranged in reverse order in the package. He said that each woman's case was unique - given whether she became pregnant, whether she carried the pregnancy to term, the relevant laws in her state, and whether she kept the package or receipt - and should be weighed individually.

"It is not enough that each class member prove that defendants sold a defective product," Jones wrote. "Each plaintiff must show in an individualized manner which 'physical symptoms' she suffered, her medical history, and whether her use of any allegedly defective product resulted in these physical symptoms or a pregnancy."

The recall involved the brand names Cyclafem, Emoquette, Gildess, Orsythia, Previfem and Tri-Previfem.

Each packet of birth control contains 28 days' worth of pills, with 21 containing hormones that prevent pregnancy and seven placebos pills. Women are supposed to take the pills in order and not mix the placebos with the active pills. The pills are normally color-coded to note the difference.

Laws in some states allow women to sue over the cost of raising a child to age 18, according to lawyer Keith Bodoh of Marietta, Georgia, who filed the Philadelphia lawsuit. Damages in a few states could include the cost of college. But the formula in four states involves the cost of raising a child minus the presumed benefits.

"It's amorphous, what to decide (is) the cost and benefit of rearing a child," Bodoh said this week

Endo International plc (ENDPQ) Stock Research Links

ENDPQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 36

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 36

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 44

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 36

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 42

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 29

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 46

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Alcoa Corporation Surges Amidst Market Uncertainties and Earnings

Updated Category News Views 193

Alcoa Corporation's Financial Performance Amid Market Fluctuations In today's unpredictable market, Alcoa Corporation (NYSE: AA) has emerged with financial insights reflecting the ongoing changes in the aluminum industry. Their recent quarter showed some fluctuations, offering a valuable perspective on how they are navigating these challenges. Impressive Revenue Figures...

Continue Reading
BCE's Preferred Shares Conversion Unpacks Investor Moves

Updated Category News Views 5

Exploring BCE's Preferred Share Shift Some days it's just about reading between the lines of corporate moves. Today, BCE Inc., that giant of the North you've probably caught a quote or two from on the TSX as BCE, tossed out a fresh update. And it ain't just any old news—the conversion of preferred shares from Series AJ to Series AI, to be exact. If you're shaking your...

Continue Reading
Trump Administration Freezes NYC Infrastructure Funds Amid Controversy

Updated Category News Views 314

Trump's Decision to Withhold NYC Infrastructure Funding The Trump administration has recently made a significant decision to withhold $18 billion in federal funds from New York City. This decision particularly affects two major infrastructure projects that are vital for enhancing transportation. Impact on Major Transportation Projects The funds in question are intended...

Continue Reading
Rosen Law Firm Initiates Class Action for Moderna Shareholders

Updated Category News Views 120

Class Action Lawsuit Against Moderna, Inc. Rosen Law Firm, a respected global investor rights law firm, is bringing attention to a class action lawsuit filed on behalf of all individuals who purchased securities of Moderna, Inc. (NASDAQ: MRNA) through a specified timeframe. Moderna is a biotechnology leader recognized for discovering and commercializing messenger RNA...

Continue Reading
Toll Brothers: A 20-Year Investment That Paid Off

Updated Category News Views 64

Exploring Toll Brothers' Investment Growth Toll Brothers (NYSE: TOL) has shown impressive growth in the stock market, consistently outperforming many competitors for the past two decades. Investors who made a modest investment in TOL two decades ago have enjoyed substantial returns. The average annualized return is currently at 9.4%, underscoring the company's success in...

Continue Reading